Intermountain, Syapse Team on Clinical Genomics Service for Oncologists | GenomeWeb

NEW YORK (GenomeWeb) – Syapse and Intermountain Healthcare said today that they will collaborate to offer Intermountain's network of oncologists, tools for genomics-driven cancer care.

Intermountain is a non-profit system of 22 hospitals, 185 physician clinics, and an affiliated health insurance company. It selected Syape's software to provide oncologists with access to tumor genome profiling, data analysis, and drug procurement services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.